Initial Statement of Beneficial Ownership (3)
12 Januar 2023 - 12:44AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Hammett Richard A |
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2023
|
3. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [HCA]
|
(Last)
(First)
(Middle)
ONE PARK PLAZA |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Group President / |
(Street)
NASHVILLE, TN 37203
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 7709 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Restricted Stock Units | 1/30/2023 | 1/30/2029 | Common Stock | 598 | (1) | D | |
Restricted Stock Units | (2) | 1/29/2030 | Common Stock | 1200 | (1) | D | |
Stock Appreciation Right | (3) | 5/1/2030 | Common Stock | 13850 | $104.86 | D | |
Stock Appreciation Right | (4) | 2/3/2031 | Common Stock | 9160 | $173.12 | D | |
Stock Appreciation Right | (5) | 1/28/2032 | Common Stock | 6930 | $236.61 | D | |
Explanation of Responses: |
(1) | Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock. |
(2) | The restricted stock units vest in two equal annual installments beginning January 29, 2023. |
(3) | The stock appreciation rights vest in four equal annual installments beginning on May 1, 2021. |
(4) | The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. |
(5) | The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Hammett Richard A ONE PARK PLAZA NASHVILLE, TN 37203 |
|
| Group President |
|
Signatures
|
/s/ Kevin A. Ball, Attorney-in-Fact | | 1/11/2023 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024